Home

Avalon Ventures IX, L.P.

CIK 1493612 · last filed 2014-02-05

Avalon Ventures IX, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2013. The most recent filing shows the insider sold $31.4M of PETX on Feb 5, 2014. Across all open-market trades the lifetime net is −$25.4M, making them a net seller over the disclosed history. The firm reports its address in La Jolla, CA.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

3

Lifetime Open-Market Net

-$25.35M

Filer Profile

Reported Address
1134 KLINE STREET
LA JOLLA, CA 92037
Phone
(858) 348-2180
State of Incorporation
DE
Related Filers
Avalon Ventures VIII LP — same reported address
Avalon Ventures X, L.P. — same reported address
Avalon Ventures XI, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARATANA THERAPEUTICS, INC. (PETX) Delisted 10%+ Owner 3,345,543 — — -$25.35M 3 2014-02-05

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-02-05 ARATANA THERAPEUTICS, INC. (PETX) Delisted Sell (S) −1,650,000 -$31.35M EDGAR
2013-07-08 ARATANA THERAPEUTICS, INC. (PETX) Delisted Mixed +7,869,232 $6.00M EDGAR
2013-07-05 ARATANA THERAPEUTICS, INC. (PETX) Delisted Conv (C) +6,869,232 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.